Tenascin-C drives persistence of organ fibrosis
Systemic sclerosis (SSc) is a fibrotic disease affecting multiple organs. Here the authors use patient samples plus mouse studies to show a central role for tenascin C as a TLR4 activator responsible for persistence of fibrosis in the context of SSc and SSc-like disease.
Main Authors: | Swati Bhattacharyya, Wenxia Wang, Luisa Morales-Nebreda, Gang Feng, Minghua Wu, Xiaodong Zhou, Robert Lafyatis, Jungwha Lee, Monique Hinchcliff, Carol Feghali-Bostwick, Katja Lakota, G. R. Scott Budinger, Kirtee Raparia, Zenshiro Tamaki, John Varga |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11703 |
Similar Items
-
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
by: Swati Bhattacharyya, et al.
Published: (2018-10-01) -
Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.
by: Katja Lakota, et al.
Published: (2015-01-01) -
Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis
by: Ludivine Renaud, et al.
Published: (2024-06-01) -
Tenascin-C in fibrosis in multiple organs: translational implications
by: Bhattacharya, S, et al.
Published: (2022) -
The evolution of tenascins
by: Josephine C. Adams, et al.
Published: (2024-09-01)